Industry Growth Insights published a new data on “Human Growth Hormone Drugs Market”. The research report is titled “Human Growth Hormone Drugs Market research by Types (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope - the Somatropin Biosimilar, Somatropin Biopartners), By Applications (Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome), By Players/Companies Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany), Eli Lilly and Company (US)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Growth Hormone Drugs Market Research Report
By Type
Norditropin, Genotropin, Humatrope, Saizen, Omnitrope - the Somatropin Biosimilar, Somatropin Biopartners
By Application
Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome
By Companies
Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany), Eli Lilly and Company (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Human Growth Hormone Drugs Market Report Segments:
The global Human Growth Hormone Drugs market is segmented on the basis of:
Types
Norditropin, Genotropin, Humatrope, Saizen, Omnitrope - the Somatropin Biosimilar, Somatropin Biopartners
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly and Company (US)
- Ferring Holding SA (Switzerland)
- Genentech, Inc. (US)
- GeneScience Pharmaceuticals Co., Ltd. (China)
- Merck KgaA (Germany)
- Novo Nordisk A/S (Denmark)
- Pfizer, Inc. (US)
- Sandoz International GmbH (Germany)
- Eli Lilly and Company (US)
Highlights of The Human Growth Hormone Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Norditropin
- Genotropin
- Humatrope
- Saizen
- Omnitrope - the Somatropin Biosimilar
- Somatropin Biopartners
- By Application:
- Prader-Willi Syndrome
- Turner Syndrome
- Short Stature Homeobox Gene
- Small for Gestational Age
- Chronic Renal Insufficiency
- Short Bowel Syndrome
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Growth Hormone Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human growth hormone (HGH) is a natural substance that stimulates the body to produce more HGH. This can help improve overall health and well-being by promoting muscle growth, reducing fat storage, and improving bone density.
Some of the major companies in the human growth hormone drugs market are Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany), Eli Lilly and Company (US).
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Growth Hormone Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Growth Hormone Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Growth Hormone Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Growth Hormone Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Growth Hormone Drugs Market Size & Forecast, 2020-2028
4.5.1 Human Growth Hormone Drugs Market Size and Y-o-Y Growth
4.5.2 Human Growth Hormone Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Norditropin
5.2.2 Genotropin
5.2.3 Humatrope
5.2.4 Saizen
5.2.5 Omnitrope - the Somatropin Biosimilar
5.2.6 Somatropin Biopartners
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Prader-Willi Syndrome
6.2.2 Turner Syndrome
6.2.3 Short Stature Homeobox Gene
6.2.4 Small for Gestational Age
6.2.5 Chronic Renal Insufficiency
6.2.6 Short Bowel Syndrome
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Growth Hormone Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Growth Hormone Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Norditropin
9.6.2 Genotropin
9.6.3 Humatrope
9.6.4 Saizen
9.6.5 Omnitrope - the Somatropin Biosimilar
9.6.6 Somatropin Biopartners
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Prader-Willi Syndrome
9.10.2 Turner Syndrome
9.10.3 Short Stature Homeobox Gene
9.10.4 Small for Gestational Age
9.10.5 Chronic Renal Insufficiency
9.10.6 Short Bowel Syndrome
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Norditropin
10.6.2 Genotropin
10.6.3 Humatrope
10.6.4 Saizen
10.6.5 Omnitrope - the Somatropin Biosimilar
10.6.6 Somatropin Biopartners
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Prader-Willi Syndrome
10.10.2 Turner Syndrome
10.10.3 Short Stature Homeobox Gene
10.10.4 Small for Gestational Age
10.10.5 Chronic Renal Insufficiency
10.10.6 Short Bowel Syndrome
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Norditropin
11.6.2 Genotropin
11.6.3 Humatrope
11.6.4 Saizen
11.6.5 Omnitrope - the Somatropin Biosimilar
11.6.6 Somatropin Biopartners
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Prader-Willi Syndrome
11.10.2 Turner Syndrome
11.10.3 Short Stature Homeobox Gene
11.10.4 Small for Gestational Age
11.10.5 Chronic Renal Insufficiency
11.10.6 Short Bowel Syndrome
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Norditropin
12.6.2 Genotropin
12.6.3 Humatrope
12.6.4 Saizen
12.6.5 Omnitrope - the Somatropin Biosimilar
12.6.6 Somatropin Biopartners
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Prader-Willi Syndrome
12.10.2 Turner Syndrome
12.10.3 Short Stature Homeobox Gene
12.10.4 Small for Gestational Age
12.10.5 Chronic Renal Insufficiency
12.10.6 Short Bowel Syndrome
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Norditropin
13.6.2 Genotropin
13.6.3 Humatrope
13.6.4 Saizen
13.6.5 Omnitrope - the Somatropin Biosimilar
13.6.6 Somatropin Biopartners
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Prader-Willi Syndrome
13.10.2 Turner Syndrome
13.10.3 Short Stature Homeobox Gene
13.10.4 Small for Gestational Age
13.10.5 Chronic Renal Insufficiency
13.10.6 Short Bowel Syndrome
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Growth Hormone Drugs Market: Competitive Dashboard
14.2 Global Human Growth Hormone Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly and Company (US)
14.3.2 Ferring Holding SA (Switzerland)
14.3.3 Genentech, Inc. (US)
14.3.4 GeneScience Pharmaceuticals Co., Ltd. (China)
14.3.5 Merck KgaA (Germany)
14.3.6 Novo Nordisk A/S (Denmark)
14.3.7 Pfizer, Inc. (US)
14.3.8 Sandoz International GmbH (Germany)
14.3.9 Eli Lilly and Company (US)
